NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/28/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization1,119,492 mln
Float889 mln
Earnings Date10/29/2026
EPS
29.75
Exceptional
P / E
39.48
Overvalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-1.68
Likely manipulated
1-Year Forecast
1,315
Modest upside
Relative Strength
51
/ 100
In line with market
Business Description
Founded in 1876 and based in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical company that researches, produces, and sells medicines across the United States, Europe, Asia, and beyond. Its product portfolio spans several major health areas, including diabetes and weight management, cancer treatment, immune system disorders, and neurological conditions such as migraines and Alzheimer's disease. The company also works alongside partners like Boehringer Ingelheim, Roche, and Genentech to bring additional treatments to market.
